Teva Pharmas Turnaround Story How A Key Win Helped It Clinch A Five-Year High - Investors Business Daily
| 106190 Stock | KRW 14,030 60.00 0.43% |
About 62% of High Tech's investor base is looking to short. The analysis of current outlook of investing in High Tech Pharm suggests that many traders are alarmed regarding High Tech's prospects. The current market sentiment, together with High Tech's historical and current headlines, can help investors time the market. In addition, many technical investors use High Tech Pharm stock news signals to limit their universe of possible portfolio assets.
High |
Teva Pharmas Turnaround Story How A Key Win Helped It Clinch A Five-Year High Investors Business Daily
Read at news.google.com
 |
High Tech Fundamental Analysis
We analyze High Tech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of High Tech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of High Tech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
High Tech is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
High Tech Pharm Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with High Tech stock to make a market-neutral strategy. Peer analysis of High Tech could also be used in its relative valuation, which is a method of valuing High Tech by comparing valuation metrics with similar companies.
Peers
High Tech Related Equities
| 016610 | DB Financial | 0.19 |
| ||
| 211050 | Incar Financial | 0.31 |
| ||
| 045340 | Total Soft | 0.64 |
| ||
| 020180 | Daishin Information | 0.69 |
| ||
| 010280 | Ssangyong Information | 0.80 |
| ||
| 025770 | Korea Information | 0.85 |
| ||
| 118000 | Chorokbaem Healthcare | 1.59 |
| ||
| 071200 | INFINITT Healthcare | 2.39 |
|
Complementary Tools for High Stock analysis
When running High Tech's price analysis, check to measure High Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy High Tech is operating at the current time. Most of High Tech's value examination focuses on studying past and present price action to predict the probability of High Tech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move High Tech's price. Additionally, you may evaluate how the addition of High Tech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stocks Directory Find actively traded stocks across global markets |